These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 17698332)

  • 1. Involvement of the renin-angiotensin system in obesity: older and newer pathways.
    Galletti F; Strazzullo P
    Nutr Metab Cardiovasc Dis; 2007 Dec; 17(10):699-704. PubMed ID: 17698332
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypertension, obesity, and the renin-angiotensin system: a tale of tight associations.
    Sibley S
    Minn Med; 2003 Jan; 86(1):46-8. PubMed ID: 12585560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The problem of obesity: is there a role for antagonists of the renin-angiotensin system?
    Weisinger RS; Begg DP; Chen N; Jois M; Mathai ML; Sinclair AJ
    Asia Pac J Clin Nutr; 2007; 16 Suppl 1():359-67. PubMed ID: 17392133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mineralocorticoid-stimulating activity of adipose tissue.
    Lamounier-Zepter V; Ehrhart-Bornstein M; Bornstein SR
    Best Pract Res Clin Endocrinol Metab; 2005 Dec; 19(4):567-75. PubMed ID: 16311217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physiology and pathophysiology of the adipose tissue renin-angiotensin system.
    Engeli S; Negrel R; Sharma AM
    Hypertension; 2000 Jun; 35(6):1270-7. PubMed ID: 10856276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of renin-angiotensin system in adipose tissue dysfunction.
    Iwai M; Horiuchi M
    Hypertens Res; 2009 Jun; 32(6):425-7. PubMed ID: 19407825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adipose cell-adrenal interactions: current knowledge and future perspectives.
    Ronconi V; Turchi F; Bujalska IJ; Giacchetti G; Boscaro M
    Trends Endocrinol Metab; 2008 Apr; 19(3):100-3. PubMed ID: 18299203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renin-angiotensin system, natriuretic peptides, obesity, metabolic syndrome, and hypertension: an integrated view in humans.
    Sarzani R; Salvi F; Dessì-Fulgheri P; Rappelli A
    J Hypertens; 2008 May; 26(5):831-43. PubMed ID: 18398321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hypertension in obesity].
    Skórka B; Chlebus H
    Pol Tyg Lek; 1984 Apr; 39(15):513-7. PubMed ID: 6384963
    [No Abstract]   [Full Text] [Related]  

  • 10. [Development of adipose tissue in the normal and obese child].
    Rocour-Brumioul D; Bonnet F
    Rev Prat; 1980 May; 30(27):1751-61. PubMed ID: 7455540
    [No Abstract]   [Full Text] [Related]  

  • 11. Adrenocortical dysregulation as a major player in insulin resistance and onset of obesity.
    Roberge C; Carpentier AC; Langlois MF; Baillargeon JP; Ardilouze JL; Maheux P; Gallo-Payet N
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1465-78. PubMed ID: 17911338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross talk of tumor necrosis factor-alpha and the renin-angiotensin system in tumor necrosis factor-alpha-induced plasminogen activator inhibitor-1 production from hepatocytes.
    Takeshita Y; Takamura T; Ando H; Hamaguchi E; Takazakura A; Matsuzawa-Nagata N; Kaneko S
    Eur J Pharmacol; 2008 Jan; 579(1-3):426-32. PubMed ID: 18078928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiologists set to become obesity experts?
    Cardiovasc J Afr; 2007; 18(3):189. PubMed ID: 17612755
    [No Abstract]   [Full Text] [Related]  

  • 14. Noninvasive assessment of left atrial function by strain rate imaging in patients with hypertension: a possible beneficial effect of Renin-Angiotensin system inhibition on left atrial function.
    Song ZZ
    Hypertens Res; 2008 Mar; 31(3):585; author reply 585-6. PubMed ID: 18497480
    [No Abstract]   [Full Text] [Related]  

  • 15. Can we live without a functional renin-angiotensin system?
    Corvol P; Michaud A; Gribouval O; Gasc JM; Gubler MC
    Clin Exp Pharmacol Physiol; 2008 Apr; 35(4):431-3. PubMed ID: 18307735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variation and activity of the renin-angiotensin system and severe hypoglycemia in type 1 diabetes.
    Pedersen-Bjergaard U; Dhamrait SS; Sethi AA; Frandsen E; Nordestgaard BG; Montgomery HE; Pramming S; Hougaard P; Thorsteinsson B
    Am J Med; 2008 Mar; 121(3):246.e1-8. PubMed ID: 18328310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adipokines as novel modulators of lipid metabolism.
    Lago F; Gómez R; Gómez-Reino JJ; Dieguez C; Gualillo O
    Trends Biochem Sci; 2009 Oct; 34(10):500-10. PubMed ID: 19729309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expanded adipose tissue: 'out of breath' and inflamed.
    Sell H; Eckel J
    Br J Nutr; 2008 Aug; 100(2):236-7. PubMed ID: 18384704
    [No Abstract]   [Full Text] [Related]  

  • 19. Obesity, inflammation, and macrophages.
    Subramanian V; Ferrante AW
    Nestle Nutr Workshop Ser Pediatr Program; 2009; 63():151-9; discussion 159-62, 259-68. PubMed ID: 19346774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of the renin-angiotensin system in the pathophysiology, prevention, and treatment of renal impairment in patients with the cardiometabolic syndrome or its components.
    Alpert MA; Govindarajan G; Del Rosario ML; Reisin E
    J Cardiometab Syndr; 2009; 4(1):57-62. PubMed ID: 19245518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.